Pembrolizumab and Lenvatinib in Patients With High Risk Locally Advanced Cervix Cancer
Erasmus Medical Center
Erasmus Medical Center
Regeneron Pharmaceuticals
National Institutes of Health Clinical Center (CC)
University of South Alabama
University Health Network, Toronto
Quest PharmaTech Inc.
AIO-Studien-gGmbH
Novartis